PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)

  • ID: 4240782
  • Report
  • Region: Global
  • 427 Pages
  • Kalorama Information
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Autogenomics, Inc.
  • Curetis
  • Genmark Diagnostics, Inc.
  • Mast Group
  • Quidel, Inc.
  • MORE

Polymerase chain reaction (PCR) technology was the first of what are now many nucleic acid amplification testing (NAAT) methods that have been developed and commercialized. PCR technology is widely used for both life science (research) market and diagnostic applications, with many companies active in these fields. Real-time PCR (qPCR) has become the most widely used DNA amplification method today. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) examines the markets for life science and clinical applications of PCR and Other NAAT technologies.

The report contains in-depth information on PCR (qPCR, dPCR and other NAAT), breaking the market opportunity down by type of NAAT, instruments versus consumables, market segment, disease indication, and type of infection, including the following data points:

  • Nucleic Acid Amplification Test Market, Worldwide, 2016 and 2021 (All NAATs: Life Science NAAT Market, Clinical NAAT Market, Other NAAT Market, Total NAAT Market)
  • Life Science PCR Market, Instruments versus Consumables, Worldwide, 2016 and 2021 (Reagents/Consumables, Instruments, Software & Services, Total life science PCR market)
  • Life Science PCR Market, by Type of PCR, Worldwide, 2016 (%) (qPCR, dPCR)
  • Life Science PCR Market, by Type of PCR, Worldwide, 2021 (%) (qPCR, dPCR)
  • Diagnostic PCR and Other NAAT Market by Disease Indication, Worldwide, 2016 and 2021 (Infectious Disease, Oncology, Genetic Testing, Transplantation Diagnostics, Other; Total Diagnostics Segment; Blood Screening; Total Clinical NAAT Market)
  • Diagnostic PCR and Other NAAT Market, by Type of NAAT, Worldwide, 2016 (%) (PCR, TMA, Other NAAT)
  • Diagnostic PCR and Other NAAT Market, by Type of NAAT, Worldwide, 2021 (%) (PCR, TMA, Other NAAT)
  • Diagnostic Infectious Disease PCR and Other NAAT Market by Type of Infection, Worldwide, 2016 and 2021 (Hepatitis, HIV, Healthcare Acquired Infections and Sepsis, Respiratory Pathogens, Sexually Transmitted Diseases and Women’s Health, Tuberculosis, Other, Total)
  • Diagnostic Oncology PCR and Other NAAT Market (Screening, Diagnosis/Prognosis/Personalized Medicine/Monitoring) Worldwide, 2016 and 2021 (Cancer screening market, Cancer diagnostics market, Total cancer NAAT market)
  • Diagnostic PCR and Other NAAT Genetic Testing Market by Market Segment, Worldwide, 2016 and 2021 (Inherited Diseases, Thrombophilia, Pharmacogenomics, Total genetic testing market)

The PCR (qPCR, dPCR and other NAAT) market coverage is regional as well, providing the following geographic breakouts for the infectious disease PCR market, PCR oncology or cancer diagnostics, and PCR genetic testing segment, among others:

  • Life Science PCR Market, by Geographical Distribution (%) (U.S., Europe, Japan, ROW)
  • Clinical PCR and Other NAAT Market by Geographical Region, Worldwide, 2016 and 2021 (United States, Europe, Japan, China, Latin America, Rest of World, Total Clinical NAAT Market)
  • Diagnostic Infectious Disease PCR and Other NAAT Market, Worldwide by Geographical Region, 2016 and 2021 (United States, Europe, Japan, China, Latin America, Rest of World, Total - World)
  • Diagnostic Oncology PCR and Other NAAT Market by Geographical Distribution, Worldwide, 2016 and 2021 (United States, Europe, Japan, China, Latin America, Rest of World, World)
  • Diagnostic Inherited Disease PCR and Other NAAT Market by Geographical Distribution, Worldwide, 2016 and 2021 (United States, Europe, Rest of World, World)
  • Diagnostic Transplantation Diagnostics PCR and Other NAAT Market by Geographical Distribution, Worldwide, 2016 and 2021 (United States, Europe, Japan, Rest of World, World)
  • PCR and Other NAAT Blood Screening Market, by Geographical Distribution, Worldwide, 2016 and 2021 (United States, Europe, Japan, China, Latin America, Rest of World, Total)

Beyond these market size and regional estimates and forecasts for both the life science (research) and diagnostic uses of PCR, the report provides an overview of PCR and other NAAT technologies, in addition to discussion of applications of NAAT in life science and clinical diagnostics.

PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) also includes financial information on deals made by PCR and other NAAT companies, including investments and financing agreements, acquisitions, collaborations, and other agreements

Market drivers and challenges in the nucleic acid amplification test market are discussed as well. Issues of growth, competition, market opportunities, regulation, reimbursement, and prospects for the future are reviewed. Some NAAT-based tests are laboratory developed tests (LDTs); the implications of this are discussed. The clinical NAAT market is driven by the need for the information generated by testing. Market changes such as the emergence of new pathogens (such as the Zika virus), or the increasing problem of antibiotic resistance, or other changes are driving the need for specific tests.

The report contains profiles of companies in the market, reflecting the wide range NAAT products and applications in both the life science PCR market and the clinical PCR market. A wide range of industry players is examined, including companies marketing NAAT instruments and/or consumables to the life science research market, companies developing or marketing in vitro diagnostic (IVD) NAAT platforms and tests to clinical laboratories, diagnostic companies offering NAAT tests as a service via their own CLIA-certified laboratory, companies developing or marketing NAAT platforms and tests for rapid point-of-care or near-patient testing, companies developing or marketing PCR-based sample/library preparation products or test panels for DNA sequencing, companies developing or marketing mass spectrometry platforms that include PCR amplification before analysis by mass spectrometry, and companies developing or marketing other technology platforms that include PCR amplification as an initial or early step.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Autogenomics, Inc.
  • Curetis
  • Genmark Diagnostics, Inc.
  • Mast Group
  • Quidel, Inc.
  • MORE

1: Executive Summary

  • Nucleic Acid Amplification Testing Overview
  • Scope And Methodology
  • Market Overview
    • Table 1-1: PCR And Other NAAT Market, Worldwide, 2016 And 2021 [All NAATs - Life Science And Clinical Markets] (In Millions USD)
  • Future Prospects In The PCR Market

2: Introduction

  • Development And Evolution Of Polymerase Chain Reaction And Other Nucleic Acid Amplification Tests
    • Development And Evolution Of PCR
    • Other Nucleic Acid Amplification Test Methods
    • Advances In Nucleic Acid Amplification Technology And Emerging Applications
  • Point-Of-View

3: Technology Trends And Innovation

  • Polymerase Chain Reaction (PCR) - Overview
  • PCR, Rt-PCR, And QPCR
    • Digital PCR
    • Table 3-1: Selected Companies With Digital PCR Technology (For Research And/Or Diagnostic Tests)
    • Multiplex PCR
    • Table 3-2: Selected Companies With Multiplex PCR Technology [Note: This Is Not A Comprehensive List Of All Companies With Multiplex PCR Technology/Tests.]
    • Other Modifications Of PCR
    • Table 3-3: Selected Companies With Innovative PCR-Based Methods
  • Other  Nucleic Acid Amplification Test (NAAT) Methods
    • Isothermal NAAT Methods In Clinical Laboratories
    • Rapid Isothermal NAAT Methods In Decentralized Settings - Near Patient And Point-Of-Care
    • Table 3-4: Companies With Other Nucleic Acid Amplification Test Methods
  • Platforms Used In Different NAAT Markets - Research, Clinical Laboratories, And Point-Of-Care Testing
    • Table 3-5: Selected Companies Marketing PCR Instruments/Reagents To The Life Sciences Market
    • Table 3-6: Selected Companies Marketing NAAT Platforms/Tests To Clinical Laboratories
    • Table 3-7: Selected Companies With NAAT Platforms And Tests For Decentralized Testing Or Point-Of-Care Settings
  • New Applications Of PCR - Combining PCR With Other Technologies
  • PCR As Part Of Sample Prep Before Dna Sequencing
    • Table 3-8: Examples Of Companies Using PCR During Sample Prep Before Dna Sequencing
  • PCR Before Mass Spectrometry
    • Table 3-9: Selected Companies Developing Platforms That Use PCR Before Analysis By Mass Spectrometry
    • Other Technologies Being Used With PCR
    • Table 3-10: Selected Companies Using PCR With Other Technologies (Beyond Sequencing And Mass Spectrometry)

4: Nucleic Acid Amplification Tests In Research And The Clinical Laboratory

  • Research Applications Of Polymerase Chain Reaction
  • Infectious Disease Diagnostics
    • Infectious Disease Diagnostic Tests
    • Table 4-1: Selected Common Microorganisms Detected By Clinical NAAT Tests
    • Table 4-2: Selected Companies Marketing PCR/NAAT Infectious Disease Tests (Single Or Limited Number Of Analytes)
    • Table 4-3: Selected Companies Marketing PCR/NAAT Syndromic Tests/Panels For Infectious Diseases
    • Antibiotic Resistance/Susceptibility Testing
    • Table 4-4: Selected Companies Marketing PCR/NAAT-Based Antibiotic Resistance/Susceptibility Tests
    • Rapid Near-Patient Or Point-Of-Care Testing For Infectious Diseases
    • Table 4-5: Selected Companies Marketing Rapid Near-Patient/Point-Of-Care PCR/NAAT Infectious Disease Tests
    • Table 4-6: Clia Waived NAAT Infectious Disease Tests
  • Oncology
    • Cancer Risk
    • Cancer Screening
    • Table 4-7: Selected Companies Developing/Marketing Diagnostic Tests For Hpv
    • Table 4-8: Selected Companies Developing/Marketing PCR/NAAT Tests For Cancer Screening (Not Including Hpv Tests For Cervical Cancer)
    • Cancer Diagnostics (Diagnosis, Prognosis, Monitoring, Response To Therapy)
    • Table 4-9: Selected Companies Developing/Marketing PCR/NAAT Tests For Diagnosis/Prognosis/Predicting Response To Cancer Therapy
    • Table 4-10: Selected PCR/NAAT Based, Fda Cleared/Approved Companion Diagnostic Tests
  • Cardiovascular Disease
    • Table 4-11: Selected Companies Developing/Marketing PCR Tests For Risk Of Thrombophilia
    • Table 4-12: Selected Companies Developing/Marketing PCR Warfarin Sensitivity Tests
    • Table 4-13: Selected Companies Developing/Marketing Other PCR-Based Cardiovascular Tests
  • Genetic Testing
    • Inherited (Genetic) Disorders
    • Table 4-14: Selected Companies Developing/Marketing PCR Tests For Risk Of Inherited (Genetic) Disorders
    • Drug Metabolism - Pharmacogenomics Testing
    • Table 4-15: Pharmacogenomic Biomarkers In Drug Labeling
    • Table 4-16: Selected Companies Developing/Marketing PCR Tests For Pharmacogenomics (Drug Metabolism)
  • Hla Typing
    • Table 4-17: Selected Companies Developing/Marketing PCR Tests For Hla Typing
  • Other Clinical Applications Of Polymerase Chain Reaction
    • Table 4-18: Selected Companies Developing/Marketing PCR Tests For Other Clinical Applications
  • Transfusion Medicine - Blood Screening
    • Table 4-19: Selected Companies Developing/Marketing PCR Tests Transfusion Medicine
  • Non-Clinical Applications Of Polymerase Chain Reaction

5: Deals - Polymerase Chain Reaction/Nucleic Acid Amplification Test Companies

  • Investments And Financing Agreements
    • Table 5-1: Selected Investment And Financing Agreements In NAAT Companies
  • Mergers And Acquisitions
    • Table 5-2: Selected Acquisitions Of NAAT Companies
  • Corporate Agreements And Collaborations (Not Including Pharmaceutical Companies)
    • Table 5-3: Selected Agreements Between NAAT Companies And Other Companies [Not Including Pharmaceutical Companies]
  • Collaborations/Agreements With Pharmaceutical And Biopharmaceutical Companies
    • Table 5-4: Selected Agreements Between NAAT Companies And Pharmaceutical Or Biopharmaceutical Companies
  • Collaborations And Other Agreements With Universities, Non-Profit Research Institutes And Government
    • Table 5-5: Selected NAAT Company Agreements With Academic Or Other Non-Profit Organizations

6: Market Drivers And Challenges - Nucleic Acid Amplification Test Market

  • Issues And Hurdles Faced By PCR Companies Selling To The Research Market
  • Clinical Market Drivers
  • Point-Of-Care Testing Market Drivers And Challenges/Hurdles
  • Competition From Companies Utilizing PCR And Other NAAT Technologies
  • Competition And Market Opportunities Driven By Other (Non-NAAT) Technologies
    • Competition
    • Opportunities
  • Regulation Of In Vitro Diagnostics
  • Laboratory Developed Tests
  • Reimbursement
  • Future Prospects
    • Table 6-1: Trends In The Polymerase Chain Reaction/Nucleic Acid Amplification Test Market

7: PCR Market Analysis

  • PCR & Nucleic Acid Amplification Test Market Overview
    • Table 7-1: Nucleic Acid Amplification Test Market, Worldwide, 2016 And 2021 [All NAATs -Life Science And Clinical Markets] (In Millions USD) (Life Science NAAT Market, Clinical NAAT Market, Other NAAT Market, Total NAAT Market)
  • Life Science NAAT Market
  • Past And Future Growth Of Overall Life Science PCR Market
    • Figure 7-1: Growth Of The Life Science PCR Market (1990 - 2016) [# Abstracts Found Per Year In Pubmed Search For “’Polymerase Chain Reaction’ Or PCR”] (Accessed March 27, 2017)
    • Life Science PCR Market - Instruments Versus Consumables
    • Table 7-2: Life Science PCR Market, Instruments Versus Consumables, Worldwide, 2016 And 2021 (In Millions USD) (Reagents/Consumables, Instruments, Software & Services, Total Life Science PCR Market)
    • Life Science PCR Market - By Geographical Distribution
    • Figure 7-2: Life Science PCR Market, By Geographical Distribution (%) (U.S., Europe, Japan, Row)
    • Life Science PCR Market By Type Of PCR
    • Figure 7-3: Life Science PCR Market, By Type Of PCR, Worldwide, 2016 (%) (QPCR, DPCR)
    • Figure 7-4: Life Science PCR Market, By Type Of PCR, Worldwide, 2021 (%) (QPCR, DPCR)
  • Diagnostic PCR Market - Global Market
    • Table 7-3: Clinical PCR And Other NAAT Market By Disease Indication, Worldwide, 2016 And 2021 (In Millions USD) (Infectious Disease, Oncology, Genetic Testing, Transplantation Diagnostics, Other; Total Diagnostics Segment; Blood Screening; Total Clinical NAAT Market)
    • Table 7-4: Clinical PCR And Other NAAT Market By Geographical Region, Worldwide, 2016 And 2021 (In Millions USD) (United States, Europe, Japan, China, Latin America, Rest Of World, Total Clinical NAAT Market)
    • Figure 7-5: Clinical PCR And Other NAAT Market, By Type Of NAAT, Worldwide, 2016 (%) (PCR, Tma, Other NAAT)
    • Figure 7-6: Clinical PCR And Other NAAT Market, By Type Of NAAT, Worldwide, 2021 (%) (PCR, Tma, Other NAAT)
  • Diagnostic PCR Market Market - Infectious Disease
    • Table 7-5: Diagnostic Infectious Disease PCR And Other NAAT Market By Type Of Infection, Worldwide, 2016 And 2021 (In Millions USD) (Hepatitis, Hiv, Healthcare Acquired Infections And Sepsis, Respiratory Pathogens, Sexually Transmitted Diseases And Women’S Health, Tuberculosis, Other, Total)
    • Table 7-6: Diagnostic Infectious Disease PCR And Other NAAT Market, Worldwide By Geographical Region, 2016 And 2021 (In Millions USD) (United States, Europe, Japan, China, Latin America, Rest Of World, Total - World)
  • Diagnostic PCR Market - Oncology
    • Emerging Market For NAAT-Based Cancer Screening
    • Cancer Diagnosis/Prognosis/Personalized Medicine/Monitoring Market
    • Table 7-7: Diagnostic Oncology PCR And Other NAAT Market (Screening, Diagnosis/Prognosis/Personalized Medicine/Monitoring) Worldwide, 2016 And 2021 (In Millions USD) (Cancer Screening Market, Cancer Diagnostics Market, Total Cancer NAAT Market)
    • Table 7-8: Diagnostic Oncology PCR And Other NAAT Market By Geographical Distribution, Worldwide, 2016 And 2021 (In Millions USD) (United States, Europe, Japan, China, Latin America, Rest Of World, World)
  • Diagnostic PCR Market - Genetic Testing
    • Table 7-9: Diagnostic PCR And Other NAAT Genetic Testing Market By Market Segment (Thrombophilia, Inherited Diseases, Pharmacogenomics) Worldwide, 2016 And 2021(In Millions USD) (Inherited Diseases, Thrombophilia, Pharmacogenomics, Total Genetic Testing Market)
    • Table 7-10: Diagnostic Inherited Disease PCR And Other NAAT Market By Geographical Distribution, Worldwide, 2016 And 2021 (In Millions USD) (United States, Europe, Rest Of World, World)
  • Diagnostic PCR Market - Transplantation Diagnostics
    • Table 7-11: Diagnostic Transplantation Diagnostics PCR And Other NAAT Market By Geographical Distribution, Worldwide, 2016 And 2021 (In Millions USD) (United States, Europe, Japan, Rest Of World, World)
  • Diagnostic PCR Market
    • Table 7-12: PCR And Other NAAT Blood Screening Market, By Geographical Distribution, Worldwide, 2016 And 2021 (In Millions USD) (United States, Europe, Japan, China, Latin America, Rest Of World, Total)

8: Company Profiles

  • Abbott Laboratories
    • Recent Revenue History
    • Table 8-1: Abbott Revenues (2013 To 2016)
    • Company Overview - With A Focus On Polymerase Chain Reaction
  • Agena Bioscience, Inc.
  • Agilent Technologies Inc.
    • Recent Revenue History
    • Table 8-2: Agilent Technologies Revenues (2014, 2015, 2016)
    • Company Overview
  • Alere Inc.
    • Recent Revenue History
    • Table 8-3: Alere Inc. Revenues (2014, 2015, And First Three Quarters Of 2016)
    • Company Overview
  • Amoy Diagnostics Co., Ltd.
  • Asuragen, Inc.
  • Atlas Genetics Ltd
  • Autogenomics, Inc.
  • Beckman Coulter, Inc. (A Danaher Corporation Company)
    • Revenue History
    • Company Overview
  • Becton, Dickinson And Company (Bd)
  • Recent Revenue History
    • Table 8-4: Becton Dickinson Revenues (2014 To 2016)
    • Company Overview
  • Biocartis Group NV
  • Recent Revenue History
  • Table 8-5: Biocartis Revenues (2014 To 2016)
  • Company Overview
  • Biofire Diagnostics, Llc. (Acquired By Biomérieux)
    • Recent Revenue History And Other Financial Information
    • Company Overview
  • Biomérieux SA
    • Recent Revenue History
    • Table 8-6: Biomérieux Revenues (2013 To 2016)
    • Company Overview
  • Bio-Rad Laboratories, Inc
    • Recent Revenue History
    • Table 8-7: Bio-Rad Laboratories Net Sales (2014 To 2016)
    • Company Overview
  • Bruker Corporation
    • Recent Revenue History
    • Table 8-8: Bruker Corporation Revenues (2013 - 2016)
    • Company Overview
  • Canon Biomedical
  • Cepheid (A Danaher Company)
    • Recent Revenue History
    • Table 8-9: Cepheid Revenues (2013 - 2015)
    • Company Overview
  • Curetis
    • Recent Revenue History
    • Table 8-10: Curetis Revenues (2014, 2015, And First Three Quarters Of 2016)
    • Company Overview
  • Diasorin S.P.A.
    • Recent Revenue History
    • Table 8-11: Diasorin Revenues (2015 And 2016)
    • Company Overview
  • Eiken Chemical Co., Ltd.
    • Recent Revenue History
    • Table 8-12: Eiken Chemical Co., Ltd. Revenues (Fy2014 - Ft 2016)
    • Company Overview
  • Elitechgroup
  • Genepoc Inc.
  • Genmark Diagnostics, Inc.
    • Recent Revenue History
    • Table 8-13: Genmark Diagnostics Revenue (2013-2016)
    • Company Overview
  • Genomic Health, Inc.
    • Recent Revenue History
    • Table 8-14: Genomic Health Revenues (2014 To 2016)
    • Company Overview
  • Grifols
    • Recent Revenue History
    • Table 8-15: Grifols Revenues (2015 And 2016)
  • Company Overview
  • Hologic, Inc.
    • Recent Revenue History
    • Table 8-16: Hologic Revenues (Fy2014 - Fy 2016)
    • Company Overview
  • Invivoscribe Technologies, Inc.
  • Janssen Diagnostics (Division Of Janssen Pharmaceutica Nv)
  • Luminex Corporation
    • Recent Revenue History
    • Table 8-17: Luminex Corporation Revenues (2014 - 2016)
    • Company Overview
  • Mast Group
  • Meridian Bioscience, Inc.
    • Recent Revenue History
    • Table 8-18: Meridian Bioscience, Inc. Revenues (Fy2014 - Ft 2016)
    • Company Overview
  • Multiplicom Nv (Part Of Agilent Technologies)
  • Qiagen N.V.
    • Recent Revenue History
    • Table 8-19: Qiagen Revenues (2014, 2015, 2016)
    • Company Overview
  • Quandx Inc.
  • Quantumdx Group
  • Quidel, Inc.
    • Recent Revenue History
    • Table 8-20: Quidel Revenues (2014 - 2016)
    • Company Overview
  • Qvella Corporation
  • Raindance Technologies, Inc. (Acquired By Bio-Rad Laboratories)
  • Roche
    • Recent Revenue History
    • Table 8-21: Roche Revenues (2015 - 2016) (Mchf)
    • Table 8-22: Roche Revenues (2015 - 2016) (Musd)
    • Company Overview
  • Siemens Healthineers
    • Recent Revenue History
    • Table 8-23: Siemens Revenues (2015 - 2016) (In Millions Of Euros)
    • Company Overview
  • Spartan Bioscience Inc
  • Stat-Diagnostica
  • T2 Biosystems, Inc.
    • Recent Revenue History
    • Table 8-24: T2 Biosystems, Inc. Revenues (2014-2016)
    • Company Overview
  • Thermo Fisher Scientific, Inc.
    • Recent Revenue History
    • Table 8-25: Thermo Fisher Scientific Revenues (2014-2016)
    • Company Overview
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Agena Bioscience, Inc.
  • Agilent Technologies, Inc.
  • Alere, Inc.
  • Amoy Diagnostics Co., Ltd.
  • Asuragen, Inc.
  • Atlas Genetics, Ltd.
  • Autogenomics, Inc.
  • Beckman Coulter, Inc. (A Danaher Corporation Company)
  • Becton, Dickinson And Company (BD)
  • Biocartis Group NV
  • Biofire Diagnostics, LLC. (Acquired by bioMérieux)
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Canon Biomedical
  • Cepheid (A Danaher Company)
  • Curetis
  • Diasorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • Elitechgroup
  • Genepoc, Inc.
  • Genmark Diagnostics, Inc.
  • Genomic Health, Inc.
  • Grifols
  • Hologic, Inc.
  • Invivoscribe Technologies, Inc.
  • Janssen Diagnostics (Division of Janssen Pharmaceutica NV)
  • Luminex Corporation
  • Mast Group
  • Meridian Bioscience, Inc.
  • Multiplicom NV (Part of Agilent Technologies)
  • Qiagen N.V.
  • Quandx, Inc.
  • Quantumdx Group
  • Quidel, Inc.
  • Qvella Corporation
  • RainDance Technologies, Inc. (Acquired by Bio-Rad Laboratories)
  • Roche
  • Siemens Healthineers
  • Spartan Bioscience, Inc.
  • Stat-Diagnostica
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll